Ratings by Citizens (Jason N. Butler)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/11/2026 | CorMedix | CRMD | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/14/2025 | Precigen Inc. | PGEN | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/12/2025 | Esperion Therapeutics | ESPR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/22/2025 | Esperion Therapeutics | ESPR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/9/2025 | CorMedix | CRMD | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/18/2025 | Precigen Inc. | PGEN | Maintain | Market Outperform (N/A) |
|
Details | ||
| 6/12/2025 | Precigen Inc. | PGEN | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/15/2025 | Precigen Inc. | PGEN | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/24/2025 | Esperion Therapeutics | ESPR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/5/2025 | Esperion Therapeutics | ESPR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/11/2025 | Esperion Therapeutics | ESPR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/23/2025 | Esperion Therapeutics | ESPR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 12/30/2024 | Precigen Inc. | PGEN | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/13/2024 | Syros Pharmaceuticals | SYRS | Downgrade | Market Perform (Market Outperform) |
3.23 (0.12) |
-96.28% | Details | |
| 10/24/2024 | Marinus Pharmaceuticals | MRNS | Downgrade | Market Perform (Market Outperform) |
1.69 (0.55) |
-67.46% | Details | |
| 10/9/2024 | CorMedix | CRMD | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/15/2024 | Precigen Inc. | PGEN | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/13/2024 | Marinus Pharmaceuticals | MRNS | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/13/2024 | Syros Pharmaceuticals | SYRS | Maintain | Market Outperform (N/A) |
|
Details | ||
| 4/2/2024 | Trevena | TRVN | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/20/2024 | Precigen Inc. | PGEN | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/6/2024 | MorphoSys AG | MOR | Downgrade | Market Perform (Market Outperform) |
17.27 (18.96) |
9.79% | Details | |
| 1/29/2024 | Gamida Cell Ltd. | GMDA | Downgrade | Market Perform (Market Outperform) |
0.36 (0.03) |
-91.67% | Details | |
| 5/19/2023 | Gamida Cell Ltd. | GMDA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/19/2023 | CorMedix | CRMD | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/11/2023 | Syros Pharmaceuticals | SYRS | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/8/2023 | Marinus Pharmaceuticals | MRNS | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/1/2023 | CorMedix | CRMD | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/19/2023 | Concert Pharmaceuticals | CNCE | Downgrade | Market Perform (Market Outperform) |
6.90 (8.37) |
21.3% | Details | |
| 11/18/2022 | MorphoSys AG | MOR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/15/2022 | Syros Pharmaceuticals | SYRS | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/9/2022 | CorMedix | CRMD | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/23/2022 | Concert Pharmaceuticals | CNCE | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/22/2022 | Marinus Pharmaceuticals | MRNS | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/23/2022 | Marinus Pharmaceuticals | MRNS | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/3/2022 | Marinus Pharmaceuticals | MRNS | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/19/2022 | Zogenix, Inc. | ZGNX | Downgrade | Market Perform (Market Outperform) |
15.64 (26.68) |
70.59% | Details | |
| 11/12/2021 | Concert Pharmaceuticals | CNCE | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/25/2021 | Aquestive Therapeutics | AQST | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/18/2021 | Esperion Therapeutics | ESPR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/11/2021 | Adamas Pharmaceuticals | ADMS | Downgrade | Market Perform (Market Outperform) |
4.61 (8.22) |
78.31% | Details | |
| 9/7/2021 | CorMedix | CRMD | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/9/2021 | Cortexyme Inc. | CRTX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/5/2021 | Acadia Pharmaceuticals | ACAD | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/4/2021 | Aquestive Therapeutics | AQST | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/3/2021 | Esperion Therapeutics | ESPR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 7/19/2021 | Cytokinetics | CYTK | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/18/2021 | Concert Pharmaceuticals | CNCE | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/5/2021 | Acadia Pharmaceuticals | ACAD | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/4/2021 | Adamas Pharmaceuticals | ADMS | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/1/2021 | PLx Pharma | PLXP | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/17/2021 | Baudax Bio Inc. | BXRX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/10/2021 | Gamida Cell Ltd. | GMDA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/1/2021 | Concert Pharmaceuticals | CNCE | Maintain | Market Outperform (N/A) |
|
Details | ||
| 12/28/2020 | Myovant Sciences Ltd. | MYOV | Maintain | Market Outperform (N/A) |
|
Details | ||
| 12/21/2020 | Myovant Sciences Ltd. | MYOV | Maintain | Market Perform (N/A) |
|
Details | ||
| 12/10/2020 | Neos Therapeutics | NEOS | Downgrade | Market Perform (Market Outperform) |
0.55 (1.15) |
109.09% | Details | |
| 12/2/2020 | Ovid Therapeutics Inc | OVID | Downgrade | Market Perform (Market Outperform) |
6.84 (1.91) |
-72.08% | Details | |
| 11/12/2020 | MorphoSys AG | MOR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/20/2020 | Baudax Bio Inc. | BXRX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 9/9/2020 | Intra-Cellular Therapies | ITCI | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/10/2020 | Trevena | TRVN | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/6/2020 | Syros Pharmaceuticals | SYRS | Maintain | Market Outperform (N/A) |
|
Details | ||
| 7/13/2020 | Ovid Therapeutics Inc | OVID | Maintain | Market Outperform (N/A) |
|
Details | ||
| 6/5/2020 | Minerva Neurosciences | NERV | New Coverage | Market Outperform (N/A) |
4.26 (13.43) |
215.26% | Details | |
| 5/21/2020 | Gamida Cell Ltd. | GMDA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/7/2019 | Pfenex Inc. | PFNX | Maintain | Market Outperform (N/A) |
|
Details |
